Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great news today! This sounds like a solid study they’ve put together. If this trial achieves what Halberd has been claiming it’s capable of this is going to be HUGE. Too many possible partnerships to name!
On another note, I remember Hartman releasing a PR back in 2022 or something talking about Extendalife where their extracorporeal therapy can target certain antigens tied directly to the aging process. Remember this? I was thinking maybe Hartman himself has been doing trials with this? He has to be closer to 90 if he went to college in ‘59. Maybe he’s a walking PR for their technology!?
Oscar Wilde I am sure they are working on the extracorporeal treatment at YSU as well. LDN+ and the nasal spray are the low hanging fruit that can be marketed much faster which is why they moved to the forefront. Getting a Government contract of the scope described is huge and should move everything along big time.👍🙏🤗🔥🔥🧨🧨💥💥
Where are you Crodin Health? This should be all over the 10 oc news.
Yes I saw that. Came out this morning I believe :)
Where did you see that good news?
Good news: Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract.
Exactly. I invested here only because of the extracorporeal project. Then the nasal spray got pushed to the front.
I will say I didn’t appreciate Athena GTX’s CEO describing the extracorporeal treatment as a Sci-fi/Star Wars pie-in-the-sky idea during that interview. It’s proven capable of working and is still a large part of why I’m invested here. I wish Hartman would speak to any progress, or to its status in general, while we await news of progress from the nasal spray. A reminder to shareholders and potential investors that all our eggs aren’t in one basket would help rejuvenate some enthusiasm around this company’s potential.
Feel sorry for the guy's who bought back in the "Great HALB Pump of 2021" that are still holding.
I'm sure the bags are empty and the butts be hurtin.
So Athena gets a cut of the revenue for filing the government application. What does the government get for funding the research?
Doesn't LDN need FDA approval before approval of LDN+?
Glad to see you making $$ here flipping
Lock those shares up folks. Gives the MM less to work with. :)
I have had correspondence with him also. All my replies in " " . :)
Conflating shares awarded for spokes person with toxic financing?
I guess that is what that was???
Pretty sure we were just pointing out that there was compensation for that endorsement.
These guys. lol
What does Athena get in return?
Well, if they're not stupid (they're not) they get at least 50% of all revenue. As you know it is Athena who filed for the two government grants, a total of 6M. They will get it and because of that they guarantee all bills from MSU (nasal spray). Same with LDN+. I did some research and the road to FDA approval for LDN+ is very short. We're waiting for news about both. So far investing in $HALB has turned out very profitable. I took some profits when they "peaked", but now have more than ever, buying the dips.
How much does 333 million shares equate to? Wow!
What does Athena get in return?
Good to see you back Junkie
I've spoken with Mr Hartman and I believe he's sincerely driven to make Halberd's products a big success. I also have a Huge stash of shares, but not quite 3.5 million.
It's going to be HUGE $$$. 3.5 MIL HERE :)
1 million shares equals $8,500.00. Do you really think an $8,500.00 loan is toxic debt? Wow! I can't wait to hear about government contracts and advancement with the nasal spray at MSU.🤗👍🙏💥💥🧨🧨🔥🔥
waiting for news about the 2 gov. contracts
working on the nasal spray to treat brain damage en LDN+
partnered with Athena who pays the R&D bills
Hi Squid, nice to see you're back....
We have a couple of butt-hurt bashers on this board (can you guess who), who offer nothing but more emotionally negative diatribes that do us no good at all - Pretty sad.
Just hang on tight for good things to come.
So, I don't "get it both ways"? It wasn't just a feeling, but a fact? Oh well, can't have everything.
You da man squidster. 😜
1 million shares of BIEI and 1 million of HALB for the "endorsement".
Every new financial statement sheds more light. Look at the entry on pg. 4:
10 million shares issued to ESC on 8/12/23 to "settle debt"
But wait, Hartman said absolutely no toxic funding.
When do you think folks will figure out this ticker is nothing but a convertible note, it's all spelled out in black and white on pgs. 4-5.
https://www.otcmarkets.com/otcapi/company/financial-report/394560/content
Good luck flipping!
First & Foremost, Of course I'm not an investor in ANY PInk stock. I'm a trader of PInks.
And while I don't give credence to Forward Looking Statements in a Pink PR, I would say that when they tell us that " Carl Eller has spent the past two years as a consultant to Halberd " I tend to take it as a Fact. (I know, I'm going out on a limb with that one. lol)
If you need me to track down the exact number of shares he was paid, I can do that when I have more time, but I'm sure you remember it, from when you were reviewing the 10-K from 2021/22(?)
https://www.otcmarkets.com/stock/HALB/news/NFL-Retired-Players-Association-Endorses-Halberd-Brain-Injury-Treatment-Technology?id=367383
"Facts vs. Feelings, Hmmmm?" Your words. Seems like you question and doubt all while full of assumptions. You want it both ways but none the less your a doubter not an investor?
"The president of the NFL Retired Players Association, Carl Eller, has endorsed our product..."
Wonder if it would be more honest, to say, " After being compensated................."?
"The president of the NFL Retired Players Association, Carl Eller, has endorsed our product, but the league will not do anything with our product until we achieve full FDA certification." William A. Hartman
They have worked with the FDA before and will again. That's why we have a partnership. The need has been exposed in almost every football game this past season. FDA will come around and the sports leagues are eagerly waiting for approval. It's going to be HUGE. I'll save some for $20. :)
:)
I'm ready for some good progress. Can I heard an AMEN? :)
Jackson Center, PA February 8, 2024 – Halberd Corporation’s (OTC-PINK: “HALB”) Traumatic Brain Injury (TBI) mitigating nasal spray testing protocols at Mississippi State University (MSU) were approved by the Institutional Animal Care and Use Committee. Dr. Russell Carr, the Primary Investigator, initiated preparations for this extension of the successful Phase #1 pilot test program, completed last year with demonstrably compelling results. The advanced program will launch promptly. Numerous federal agencies expressed enthusiasm for the pursuit.
Slick Willy has moved on from saving humanity with laser therapy
https://halberdcorporation.com/halberd-demonstrates-eradication-of-cdc-provided-antibiotic-resistant-bacteria/
1 year later it's all about life saving nasal spray
https://halberdcorporation.com/halberd-and-mississippi-state-university-to-commence-stage-ii-advanced-tbi-nasal-spray-testing/
Excited to see what 2025 brings, good luck!
PR dated Feb 8, 2023... Youngstown State University (YSU) Professors and Student Scholars Successfully Conduct Research Testing. This PR describes YSU's roll in the research. Professors and students actually doing the work.
Systems Research Analyst – Immediate Opening AthenaGTX is hiring... https://athenagtx.com/about/careers/
Fair enough, but my statement was YSU is not conducting research for HALB.
YSU giving Hartman access to labs is not the same as YSU actually conducting research for HALB.
How recent was your visit? The reason I ask is the "research" done at YSU was on extracorporeal treatments and Darrah said on the last podcast the "extracorporeal research" is on the back burner while they focus on nasal spray.
Some of what you said is true but you are being dishonet about YSU's involvement. I went to YSU and talked to both Dr. Strauss and Hartman. They are definitely doing research at YSU. YSU lets Hartman use office apace to conduct research which is right down the hall from Dr. Strauss. HALB has access to the Labs also.
purrfect analogy lol
Sounds like facts to me. Damn thing has been around for what 6-7 years, done nothing but dilute and spiral into sub-penny since?
They posted fake, lying, poorly-stage videos, often, about their great breakthroughs and about anyone noticing, and the pumpers here acting like Democrats not acknowledging that Biden is dysfunctional.
Squidster, posting truth on this board is like trying to pull drowning kittens out of rushing waters, who scratch and bite your hands as you try to lift them out. Gotta' let them rot in peace bud.
Facts vs. Feelings, Hmmmm?
Propaganda suggest misleading information, which one of these statements are not accurate?
HALB has issued 333,000,000 shares since Hartman took over the ticker.
Ryan Goulding has received 285,000,000 of those shares at a cost of $99,750. shares were valued at over $10,000,000 at issuance
Ryan Goulding received 52,000,000 shares valued at $1,620,000 on 8/24/22 at issuance as compensation from a JV (Extendalife) which never came to fruition.
Ryan Goulding started a non profit entity named Epidemiological Solutions Corporation ESC. (This is where the majority of dilutive funding occurred) .
ESC committed to give HALB a $2,000,000 grant for funding research.
HALB has 164,000,000 shares left to issue before fully diluted.
As of last filing HALB still has to issue 314,690,245 shares to settle judgements payable.
HALB will have to reverse split to payoff judgement payable.
ASU is not conducting research for HALB.
Youngstown St. is not conducting research for HALB.
HALB signed a revenue sharing agreement with Athena GTX but have no product or service that will generate revenue.
William A Hartman has no skin in the game and has been living off of diluting shareowner equity for over a decade.
Anyone that can read a financial statement should have FUD. WTF?
https://www.otcmarkets.com/otcapi/company/financial-report/311582/content
https://www.otcmarkets.com/otcapi/company/financial-report/358213/content
https://www.otcmarkets.com/otcapi/company/financial-report/384904/content
https://www.otcmarkets.com/otcapi/company/financial-report/390218/content
https://www.otcmarkets.com/stock/HALB/security
Anyone that cares to refute please provide links.
And yet: https://www.barchart.com/stocks/quotes/HALB/interactive-chart
The market knows what's up
There are posters on this board who generate much fear, uncertainty and doubt (FUD). Their propaganda infers that they are the only ones who know what's going on with this company and that we longs are just a bunch of fools for investing in HALB.
This FUD flies-in-the-face of reality and the positive information that's been released regarding HALB's progress in treating many maladies/diseases that afflict people in the US and around the world - fore-shame on these gamers.
(responsible mod: Bill Moynihan/EHRjunkie)
Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.
Halberd holds the exclusive rights to 4 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629, no. 8,865,733
Halberd Corporation is a biotechnology company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University; Dr. Richard Carr and his team at Mississippi State University), is developing an extra-corporeal (out of the body) treatment against PTSD, CTE, Alzheimer's Disease and other virusses and diseases. With the use of antibodies the disease antigens is targeted. Using radiofrequency / laser technology the "antibody-metallic moiety-antigens complex" is destroyed/eradicated. All based on 4 granted patents and 22 pending provisional/non-provisional (some PCT) patent applications.
2024: In close cooperation with partner (revenue sharing agreement in place) AthenaGTX, Halberd Corp is working on contracts from the military, to develop treatments to tackle Traumatic Brain Injury/TBI (patent pending nasal spray) and Post Traumatic Stress Syndrome/PTSD (patented Low-Dose-Naltrexone product).
JACKSON CENTER, PA / ACCESSWIRE / March 14, 2023 / Halberd Corporation (OTC PINK:HALB) is scheduled to meet with Center of Disease Control (CDC) representatives to discuss Halberd's incredible success in eradicating multiple strains of antibiotic resistant (AR) E. coli bacteria and Candida auris samples previously provided by the CDC.
JACKSON CENTER, PA / ACCESSWIRE / September 6, 2023 / Halberd Corporation's (OTC PINK:HALB) research at Mississippi State University (MSU) has shown significant reduction in two key markers of traumatic brain injury (TBI) in early testing of Halberd's patent-pending nasal spray to mitigate the effects of TBI. Anecdotal data in preliminary testing reveals a 20% reduction in Neuron Specific Enolase and a 50% reduction in the levels of Glial Fibrillary Acid Protein compared to the control group.
JACKSON CENTER, PA / ACCESSWIRE / September 20, 2023 / Halberd Corporation (OTC PINK:HALB) and Athena GTX, Inc, of Johnston, Iowa commenced collaboration on critical development of submissions for government contracts seeking proposals for the detection and treatment of traumatic brain injury (TBI). The initial focus will be on accelerating and fine-tuning Halberd's proprietary nasal spray for suppressing the effects of traumatic brain injury (TBI).
JACKSON CENTER, PA / ACCESSWIRE / December 13, 2023 / Halberd Corporation (OTC PINK:HALB) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd's patented low dose naltrexone combo product(s) worldwide. The agreement also allows CrodenHealth.com right of first refusal regarding similar rights to future products in Halberd's development pipeline.
JACKSON CENTER, PA / ACCESSWIRE / January 10, 2024 / Halberd Corporation (OTC-PINK:HALB) is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa, (www.athenagtx.com). Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors.
Halberd's / Athena's treatment for PTSD is called WatchDawg
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |